Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

MPLEx_Human_Urine

ABSTRACT: Datasets of human urine samples used to test the MPLEx method.

INSTRUMENT(S): LTQ Orbitrap Velos, Exactive

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

SUBMITTER: Thomas O. Metz

PROVIDER: MSV000079407 | MassIVE | Thu Dec 03 16:57:00 GMT 2015

REPOSITORIES: MassIVE

ACCESS DATA

Json Xml

Similar Datasets

MPLEx_Arabidopsis_thaliana

Project description:Datasets of Arabidopsis thaliana samples used to test the MPLEx method

2015-12-03 | MSV000079405 | MassIVE

MPLEx_Unicyanobacterial_community

Project description:Datasets of unicyanobacterial community samples used to test the MPLEx method.

2015-12-03 | MSV000079408 | MassIVE

MPLEx_Shewanella_oneidensis

Project description:Datasets of Shewanella oneidensis samples used to test the MPLEx method.

2015-12-03 | MSV000079409 | MassIVE

MPLEx_Sulfolobus_acidocaldarius

Project description:Datasets of Sulfolobus acidocaldarius samples used to test the MPLEx method.

2015-12-03 | MSV000079410 | MassIVE

MPLEx_Mouse_Cortex

Project description:Datasets of mouse brain cortex samples used to test the MPLEx method.

2015-12-03 | MSV000079404 | MassIVE

MPLEx_Calu3

Project description:Datasets of Calu-3 cells used to test the MPLEx method.

2015-12-03 | MSV000079406 | MassIVE

An Immunosignature system for diagnosis of cancer [Cancer immunosignaturing - test 1]

Project description:This dataset contains peptide array information from 120 patients from 5 different cancer types using classic blinded test/train method. This array is library 1 (GPL17600). A 1:500 dilution of human serum is added to a peptide array (GPL17600). This array is a two-up design, with 10420 peptides printed on the top and bottom of a standard glass microscope slide. Samples were run in duplicate. The average of the duplicates are listed here. 20 train and 20 blinded test samples were run.

2013-12-15 | E-GEOD-52580 | biostudies-arrayexpress

DNA-seq of differentially induced promoter regions in E. coli UTI89 strain grown in either J82 bladder epithelial cells, urine, DMEM or LB medium.

Project description:The method DFI-seq was developed to enable identification of differentially expressed genes in uropathogenic E. coli strain UTI89 during growth in human urine and in bladder epithelial cells. By utilising this new method, the aim was to identify novel virulence genes in UTI89. DFI-seq is a combination of differential fluorescence induction (DFI) with next-generation sequencing. DFI-seq was compared to DFI by analysing gene expression of UPEC in human urine and thereby confirming that DFI-seq gives a better overview of gene expression. DFI-seq was hereafter used to look at gene expression in UTI89 while infecting bladder epithelial cells. We demonstrate the usefulness of DFI-seq for identification of genes required for optimal growth of UPEC in human urine, as well as potential virulence genes upregulated during infection of bladder epithelial cells. DFI-seq holds potential for the study of bacterial gene expression in live-animal infection systems.

2017-05-01 | E-MTAB-5657 | biostudies-arrayexpress

Global expression profile difference of hiPSCs between hESCs and human Urine-Derived Cells

Project description:Compare difference Global expression profile of hiPSCs between hESCs and human Somatic cells, showing that hiPSCs and hESCs is consistent in lineages and indicated that the induce method is safe and reliable. There are three groups of samples, each group has two repeated samples, hiPSCs respectively compared with hESCs and human Urine-Derived Cells.

2016-08-23 | E-GEOD-85885 | biostudies-arrayexpress

Detection of early-stage Alzheimer’s pathology using blood-based autoantibody biomarkers in elderly hip fracture repair patients

Project description:Human plasma samples from CDR = 0 and CDR ≥ 0.5 patients, and serum samples from non-diseased, non-surgical controls were probed onto human protein microarrays to test the utility of a previously established panel of MCI-specific autoantibody (aAB) biomarkers to detect prodromal AD presurgically in individuals admitted into the hospital for hip fracture repair (HFR) surgery.

2020-04-14 | GSE137422 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data